Fibroblast remodeling activity at two- and three-dimensional collagen-glycosaminoglycan interfaces

Biomaterials

Volumn 27, Issue 23, 2006, Pages 4212-4220

  Jaworski, Justyn ^a   Klapperich, Catherine M ^a,b  

^a Boston University   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Biocompatibility; Collagen; Glycosaminoglycan; metalloproteinases; mRNA; PCR (polymerase chain reaction)

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; COLLAGEN; INTERFACES (MATERIALS); PHASE SEPARATION; RNA;

GLYCOSAMINOGLYCAN; METALLOPROTEINASES; MRNA; PCR (POLYMERASE CHAIN REACTION);

BIOMATERIALS;

BIOMATERIAL; COLLAGEN; GLYCOSAMINOGLYCAN; GROWTH FACTOR; MATRIX METALLOPROTEINASE; POLYSTYRENE; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; MEASUREMENT; METHODOLOGY; MICROARRAY ANALYSIS; PHASE SEPARATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE;

ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; CELL LINE; COLLAGEN; FIBROBLASTS; GLYCOSAMINOGLYCANS; HUMANS;

EID: 33646142077     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.03.026     Document Type: Article

References (37)

1. Sheridan R.L., and Tompkins R.G. Skin substitutes in burns. Burns 25 2 (1999) 97-103
2. Jones I., Currie L., and Martin R. A guide to biological skin substitutes. Br J Plast Surg 55 3 (2002) 185-193
3. Lee C.H., Singla A., and Lee Y. Biomedical applications of collagen. Int J Pharm 221 1-2 (2001) 1-22
4. Kremer M., Lang E., and Berger A.C. Evaluation of dermal-epidermal skin equivalents ('composite-skin') of human keratinocytes in a collagen-glycosaminoglycan matrix(Integra artificial skin). Br J Plast Surg 53 6 (2000) 459-465
5. King P. Artificial skin reduces nutritional requirements in a severely burned child. Burns 26 5 (2000) 501-503
6. Ruszczak Z. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 55 12 (2003) 1595-1611
7. Dantzer E., and Braye F.M. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg 54 8 (2001) 659-664
8. Redekop W.K., McDonnell J., Verboom P., Lovas K., and Kalo Z. The cost effectiveness of Apligraf treatment of diabetic foot ulcers. Pharmacoeconomics 21 16 (2003) 1171-1183
9. Yannas I.V., Burke J.F., Gordon P.L., Huang C., and Rubenstein R.H. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 14 2 (1980) 107-132
10. Yannas I.V., and Burke J.F. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 14 1 (1980) 65-81
11. Klapperich C.M., and Bertozzi C.R. Global gene expression of cells attached to a tissue engineering scaffold. Biomaterials 25 25 (2004) 5631-5641
12. Orgill D.P., Straus II F.H., and Lee R.C. The use of collagen-GAG membranes in reconstructive surgery. Ann N Y Acad Sci 888 (1999) 233-248
13. Kuberka M., Heschel I., Glasmacher B., and Rau G. Preparation of collagen scaffolds and their applications in tissue engineering. Biomed Tech (Berl) 47 Suppl 1 Pt 1 (2002) 485-487
14. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 2 (2003) 249-264
15. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 2 (2003) 185-193
16. Bard J. Ontologies: formalising biological knowledge for bioinformatics. Bioessays 25 5 (2003) 501-506
17. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253 1-2 (2003) 269-285
18. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92 8 (2003) 827-839
19. Dang C.M., Beanes S.R., Lee H., Zhang X., Soo C., and Ting K. Scarless fetal wounds are associated with an increased matrix metalloproteinase-to-tissue-derived inhibitor of metalloproteinase ratio. Plast Reconstr Surg 111 7 (2003) 2273-2285
20. Mott J.D., and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16 5 (2004) 558-564
21. Braydich-Stolle L., Hussain S., Schlager J.J., and Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88 2 (2005) 412-419
22. Handsley M.M., and Edwards D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 115 6 (2005) 849-860
23. Hautamaki R.D., Kobayashi D.K., Senior R.M., and Shapiro S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277 5334 (1997) 2002-2004
24. Kolb C., Mauch S., Kranwinkel U., and Sedlacek R. Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. Exp Cell Res 250 1 (1999) 122-130
25. Mauch C. Matrix metalloproteinase-19: what role does this enzyme play in wound healing?. J Invest Dermatol 121 5 (2003) xix-xx
26. Hieta N., Impola U., Lopez-Otin C., Saarialho-Kere U., and Kahari V.M. Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture. J Invest Dermatol 121 5 (2003) 997-1004
27. Impola U., Toriseva M., Suomela S., Jeskanen L., Hieta N., Jahkola T., et al. Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. Int J Cancer 103 6 (2003) 709-716
28. van der Laan W.H., Quax P.H., Seemayer C.A., Huisman L.G., Pieterman E.J., Grimbergen J.M., et al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Ther 10 3 (2003) 234-242
29. Vaalamo M., Leivo T., and Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol 30 7 (1999) 795-802
30. Floss T., Arnold H.H., and Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev 11 16 (1997) 2040-2051
31. Finch P.W., and Rubin J.S. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv Cancer Res 91 (2004) 69-136
32. Wagener F.A., van Beurden H.E., von den Hoff J.W., Adema G.J., and Figdor C.G. The heme-heme oxygenase system: a molecular switch in wound healing. Blood 102 2 (2003) 521-528
33. Lu X.R., and Ong W.Y. Heme oxgenase-1 is expressed in viable astrocytes and microglia but in degenerating pyramidal neurons in the kainate-lesioned rat hippocampus. Exp Brain Res 137 3-4 (2001) 424-431
34. Keyse S.M., and Tyrrell R.M. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 86 1 (1989) 99-103
35. Toyoda M., Takayama H., Horiguchi N., Otsuka T., Fukusato T., Merlino G., et al. Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo. FEBS Lett 509 1 (2001) 95-100
36. Van Belle E., Witzenbichler B., Chen D., Silver M., Chang L., Schwall R., et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 97 4 (1998) 381-390
37. O'Brien F.J., Harley B.A., Yannas I.V., and Gibson L.J. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 26 4 (2005) 433-441